GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of what would you tell week-1 you about TRIUMPH — 31 comments in the full submission. View in context.
345
c/retatrutide·submitted 4 months ago by u/renzo_yildiz

what would you tell week-1 you about TRIUMPH

Resultsbranch of 8 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with…

Read the full submission and all 31 comments →

This branch

8 comments, started 4 months ago
u/ewan_zielinski8 points·4 months ago

Mechanistically the bit that matters is dose escalation. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/renzo_yildizOP5 points·4 months ago

the dosing is steep, the reflux reports are real, and nobody knows the human safety yet

replysharereportpermalink
[removed]3 points·4 months ago

[removed by moderator]

replysharereportpermalink
u/aa_analysis_andy1 point·4 months ago

the 5mg arm is different from 7.5mg, results do not transfer

replysharereportpermalink
u/rui_only_ro2 points·4 months ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/trialwatch_theotrial nerd1 point·4 months ago

the dosing is steep, the reflux reports are real, and nobody knows the human safety yet

Adding to this: TRIUMPH is doing more work than the comment implies.

replysharereportpermalink
u/honest_syringe331 point·4 months ago

Strongly agree. Heart rate escalation needs the actual data, not impressions.

replysharereportpermalink
u/jarno_cabrera2 points·4 months ago

the 2.5mg arm is different from 2.4mg, results do not transfer

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →